ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1950

ANCA-Associated Vasculitides and IgG4-Related Disease: An Overlapping Syndrome? a European Observational Study of 18 Patients

Francois-Xavier Danlos1, Giovanni Maria Rossi2, Daniel Blockmans3, Giacomo Emmi4, Andreas Kronbichler5, Stéphane Durupt6, Claire Maynard7, Luminita Luca8, Cyril Garrouste9, Bertrand Lioger10, Rachel Mourot11, Robin Dhote12, Jean-Benoit Arlet13, Thomas Hanslik14, Mikael Ebbo15, Agnès Carlotti16, Luc Mouthon17, Loïc Guillevin17, Augusto Vaglio18 and Benjamin Terrier19, 1Internal Medicine, Cochin Hospital, Paris, France, 2Nephrology, Parma, Parma, Italy, 3General Internal Medicine, University Hospitals Gasthuisberg, Leuven, Belgium, 4Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy, 5Nephrology, Hospital, Innsbruck, Austria, 6Internal Medicine, CHU, Lyon, France, 7Internal Medicine, CH, Chambéry, France, 8Internal Medicine, CHU, Poitiers, France, 9Nephrology, CHU, Clermont-Ferrand, France, 10GICC UMR 7292, University François Rabelais, Tours, France, 11Internal Medicine, CHU, Strasbourg, France, 12Service de médecine interne. Hôpital Avicenne, Paris, France, 13Service de médecine interne, Hopital Européen Georges Pompidou, Paris, France, 14Internal Medicine, CHU, Boulogne Billancourt, France, 15Internal Medicine, Aix-Marseille Université, AP-HM, Marseille, France, 16Pathology, Cochin Hospital, Paris, France, 17Department of Internal Medicine, Referral Center for Rare Autoimmune and Systemic Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France, Paris, France, 18Nephrology, University Hospital of Parma, Parma, Italy, 19National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, AP–HP, Université Paris Descartes, Paris, France

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: ANCA, IgG4 Related Disease and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2016

Title: Vasculitis - Poster II: ANCA-Associated Vasculitis

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Atypical manifestations have been described in patients with antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitides (AAV), such as periaortic fibrosis, pachymeningitis and orbital mass. Because these manifestations have been frequently described in the spectrum of IgG4-related disease (IgG4-RD), we hypothesized that both diseases could overlap.

Methods: We conducted a European retrospective multicenter observational study, including patients with AAV fulfilling 1990 ACR criteria and/or EMA algorithm and/or the definitions from the 2012 Chapel Hill Consensus Conference, and IgG4-RD fulfilling Umehara criteria. Such criteria defined IgG4-RD as possible, probable or definite. Data were collected using a standardized form by physicians in charge of patients.

Results: Eighteen patients were included (mean age 56.8 years, 13 men and 5 women). AAV and IgG4-RD diagnoses were made concomitantly in 12/18 patients (67%). AAV diagnosis preceded IgG4-RD diagnosis in 4/18 (22%) with a mean interval of 90 months (24-156), and IgG4-RD preceded AAV in 2/18 (11%). AAV diagnosis included granulomatosis with polyangiitis (GPA) in 14 (78%), microscopic polyangiitis (MPA) in 2 (12%), eosinophilic granulomatosis and polyangiitis (EGPA) in 1 (5%) and renal-limited AAV in 1 (5%). ANCA were positive in 15 patients (83%), including PR3-ANCA in 9 cases and MPO-ANCA in 5 cases. At diagnosis, mean BVAS was 16 (4-36). IgG4-RD diagnosis included definite IgG4-RD in 5 cases (28%), probable IgG4-RD in 5 (28%) and possible IgG4-RD in 8 (44%). IgG4-RD involvement were chronic periaortitis (i.e., retroperitoneal fibrosis, periaortitis and/or aortic aneurysm) in 9/18 patients (50%), orbital mass and tubulointerstitial nephritis in 4 cases each (22%), prevertebral fibrosis in 3 (16,7%), pachymeningitis and autoimmune pancreatitis in 2 cases each (11%), and salivary gland involvement, dacryoadenitis, mesenteric fibrosis, interstitial lung disease and myocardial involvement in 1 case each (5%). Medium serum IgG4 level was 2.3 g/L (range <0.07-4.85). Nineteen biopsies were performed and were contributive in 16/18 (84%) patients. Overall, 9/18 had histological evidence of vasculitis and 10/18 evidence of IgG4-RD. Histological features of IgG4-RD included dense lymphoplasmacytic infiltrate in 100% and dense fibrosis in 80%, but no obliterative phlebitis. IgG4/IgG ratio >40% was obtained in 50% and a number of IgG4-positive plasma cells >10 per high-power field in 80%. Patients required a median number of 2 (range 0-4) lines of immunosuppressants in association with corticosteroids. During a mean follow-up was 65.6 months (range 4-156), AAV relapsed in 9/18 (50%) whereas IgG4-RD relapsed in 3/18 (17%). One patient died because of diverticular peritonitis.

Conclusion: This study illustrates that AAV and IgG4-RD may overlap, suggesting that they could represent various expressions of similar Th2 dominant imbalance of T cell responses. Identification of manifestations suggesting IgG4-RD in AAV patients could be useful, in particular in case of IgG4-RD manifestations mimicking refractory granulomatous lesions.


Disclosure: F. X. Danlos, None; G. M. Rossi, None; D. Blockmans, None; G. Emmi, None; A. Kronbichler, None; S. Durupt, None; C. Maynard, None; L. Luca, None; C. Garrouste, None; B. Lioger, None; R. Mourot, None; R. Dhote, None; J. B. Arlet, None; T. Hanslik, None; M. Ebbo, None; A. Carlotti, None; L. Mouthon, None; L. Guillevin, None; A. Vaglio, None; B. Terrier, None.

To cite this abstract in AMA style:

Danlos FX, Rossi GM, Blockmans D, Emmi G, Kronbichler A, Durupt S, Maynard C, Luca L, Garrouste C, Lioger B, Mourot R, Dhote R, Arlet JB, Hanslik T, Ebbo M, Carlotti A, Mouthon L, Guillevin L, Vaglio A, Terrier B. ANCA-Associated Vasculitides and IgG4-Related Disease: An Overlapping Syndrome? a European Observational Study of 18 Patients [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/anca-associated-vasculitides-and-igg4-related-disease-an-overlapping-syndrome-a-european-observational-study-of-18-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/anca-associated-vasculitides-and-igg4-related-disease-an-overlapping-syndrome-a-european-observational-study-of-18-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology